Search results
Medicare Part D Plans Poorly Cover Adalimumab Biosimilars
Medscape· 18 hours agoThis narrow coverage limits the cost-saving potential of these biosimilar competitors, expert said.
The average retired American faces these new Medicare changes in 2025
TheStreet.com· 1 hour agoA policy announced by the Centers for Medicare and Medicaid Services involves maximum out-of-pocket expenses for seniors. There are many concerns Americans ...
CMS Redesigns the Medicare Part D Prescription Drug Program Beginning in 2025 | JD Supra
JD Supra· 4 days agoThe Final Program Instructions reflect a newly defined standard Part D benefit design through several changes or enhancements to the Part
State Retiree Health Plans Switching to Medicare Advantage
TheStreet.com· 7 hours agoMedicare Advantage is on the rise, but is it right for you? Jae Oh explains why many states are making the switch and shaking up their retiree health plans ...
What to know when enrolling in Medicare after age 65 with health issues
Las Vegas Review-Journal· 7 hours agoHer cancer treatment drugs are expensive, and I am concerned about the Medicare Part D out-of-pocket...
Enrolling in Medicare over 65 with health issues
The Salem News· 7 hours agoHer cancer treatment drugs are expensive, and I am concerned about the Medicare Part D out-of-pocket. I am a diabetic ...
Re: Recent premium increase for United Healthcare coverages
AARP· 3 hours agoMediGAP insurance is not health insurance - it makes NO decisions on your medicare care. MediGAP insurance is a financial protection product which covers ...
Prepare for Medicare Annual Enrollment Period Changes Now
TMJ4 Milwaukee· 1 day agoDuring this time people on Medicare can shop around for Medicare Advantage and Part D prescription...
Biden's Inflation Reduction Act Unravels Medicare Part D
Forbes· 7 days agoIn May, Medicare bureaucrats released new guidance that details how they'll conduct the drug pricing...
JD Supra: Better Health Care Newsletter
JD Supra· 7 hours agoFederal officials have capped the cost of insulin at $35 a month. For now, that gives relief only to patients 65 and older covered by Medicare. Big Pharma in recent years has flouted that charitable intent.